What is the recommended hormonal management for polycystic ovary syndrome, including first‑line and alternative therapy options?

Hormonal Management of PCOS

Combined oral contraceptives (COCs) are the first-line hormonal therapy for women with PCOS who are not seeking pregnancy, targeting menstrual irregularities, hyperandrogenism (hirsutism/acne), and providing endometrial protection 1.

First-Line Hormonal Treatment

For Women NOT Seeking Pregnancy

COCs should be prescribed as primary therapy to address:

• Menstrual cycle regulation
• Reduction of hirsutism and acne
• Endometrial cancer prevention (PCOS carries at least a twofold increased risk)
• Contraception 2, 3

Key considerations for COC selection:

• Use low-dose estrogen formulations to minimize venous thromboembolism (VTE) risk 3, 4
• The type of progestin matters—different formulations carry varying VTE risks 3
• Longer duration of COC treatment may reduce long-term hyperandrogenism development 1

For Adolescents with PCOS

COCs are first-line when goals include treating acne, hirsutism, anovulatory symptoms, or preventing pregnancy 1. However:

• Only initiate after Tanner stage 4-5 is reached when menarche should have occurred 1
• Consider continuing until 5 years post-menarche or substantial weight loss 1
• Metformin shows particular promise in adolescents (possibly more beneficial than in adults) for improving hyperandrogenemia, ovulation, and dyslipidemia 1

Alternative and Adjunctive Hormonal Therapies

Second-Line Options

Antiandrogens (particularly spironolactone) should be added to COCs when first-line therapy inadequately controls hirsutism or acne 2.

Critical caveat: Antiandrogens are teratogenic and must never be used without effective contraception 1. This is why they are avoided as monotherapy in adolescents who have higher contraceptive failure rates 1.

For Women with Contraindications to COCs

Progestin-only pills or cyclical progestins provide menstrual regulation and endometrial protection when estrogen is contraindicated 5.

Metabolic Management (Impacts Hormonal Profile)

Metformin is first-line therapy for metabolic complications including insulin resistance and should be added to lifestyle modifications 2. While primarily targeting metabolism, metformin improves:

• Menstrual regularity
• Hyperandrogenemia
• Ovulation rates 1

Metformin is considered second-line for menstrual cycle regulation in women with insulin resistance and dysglycemia who cannot use COCs 5.

Mandatory Risk Stratification Before COC Initiation

Before prescribing any COC, document these risk factors:

• Age and smoking status
• Obesity (BMI)
• Any glucose intolerance, prediabetes, or diabetes
• Blood pressure
• Lipid profile
• Personal or family history of VTE
• Thrombophilia screening if indicated 3, 4

Re-assess at each follow-up visit, especially if baseline risk factors exist 3. The evidence shows increased relative VTE risk with COCs, though arterial thrombosis risk is not significantly elevated in young non-smoking women 4. Morbidly obese women with severe insulin resistance may have increased diabetes risk with COC use 4.

Essential Lifestyle Foundation

All overweight/obese patients require lifestyle therapy (caloric restriction and exercise) as first-line treatment alongside hormonal management 1. This is non-negotiable and should be emphasized without weight stigma 6.

Common Pitfalls to Avoid

• Never use polycystic ovarian morphology on ultrasound or AMH levels for diagnosis in adolescents 6
• Never prescribe antiandrogens without concurrent effective contraception due to teratogenicity 1
• Do not overlook screening for depression and obstructive sleep apnea—both are increased in PCOS 2
• Do not use metformin as first-line for ovulation induction—letrozole is superior for fertility 2, 7

Treatment Algorithm Summary

Step 1: Lifestyle modification (if overweight/obese) - always foundational

Step 2: Define primary goal:

• Not seeking pregnancy + menstrual/androgen symptoms → COCs (after risk assessment)
• Not seeking pregnancy + metabolic features → Metformin + lifestyle
• Seeking pregnancy → Letrozole for ovulation induction (not hormonal management)

Step 3: Add second-line agents if needed:

• Inadequate androgen control on COCs → Add spironolactone
• COC contraindications → Progestin-only or cyclical progestins

Step 4: Monitor and reassess risk factors at each visit

The evidence base for adolescent treatment remains limited 1, but the safety profile of metformin and COCs, combined with their documented benefits, supports their use with appropriate individualized risk assessment 1.